PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
55.94
Similar ESG score to RIGL's 58.83. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
54.17
Environmental score 90-95% of RIGL's 59.08. Bill Ackman would demand clear environmental improvement catalysts.
56.72
Similar social score to RIGL's 58.66. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
56.94
Similar governance score to RIGL's 58.74. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.